Safety and Accuracy Study of Regadenoson Atropine Combination for Stress Echocardiography in Identification of Coronary Artery Disease - Related Studies

Safety and Accuracy Study of Regadenoson Atropine Combination for Stress Echocardiography in Identification of Coronary Artery Disease (REGAT)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2010 by Henry Ford Health System.
Recruitment status was Recruiting

Study NCT00894179 Information provided by Henry Ford Health System

First Received on May 4, 2009. Last Updated on June 21, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Atropine
Regadenoson

More general drug interventions related to this trial

Sponsors listed in this trial